PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Pediatrics10.3345/kjp.2018.61.2.37201861237Atypical hemolytic uremic syndrome and eculizumab therapy in childrenSeong Heon Kim, Hye Young Kim, Su Young Kimhttps://synapse.koreamed.org/pdf/10.3345/kjp.2018.61.2.37, https://synapse.koreamed.org/DOIx.php?id=10.3345/kjp.2018.61.2.37, http://kjp.or.kr/upload/pdf/kjped-61-37.pdf
American Journal of Kidney Diseases10.1053/j.ajkd.2021.02.1942021774626189 Eculizumab Therapy for Gemcitabine-Induced Atypical Hemolytic Uremic Syndromehttps://api.elsevier.com/content/article/PII:S0272638621002730?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0272638621002730?httpAccept=text/plain
Journal of Blood Medicine10.2147/jbm.s36249201639Critical appraisal of eculizumab for atypical hemolytic uremic syndromeCraig Langman, Lilian Palmahttps://www.dovepress.com/getfile.php?fileID=29844
Eye10.1038/eye.2013.1112013278997-998Resolution of ocular involvement with systemic eculizumab therapy in atypical hemolytic-uremic syndromeR David, S Hochberg-Klein, R Amerhttp://www.nature.com/articles/eye2013111.pdf, http://www.nature.com/articles/eye2013111, http://www.nature.com/articles/eye2013111.pdf
Advances in Hematology10.1155/2014/295323201420141-7Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic SyndromeHan-Mou Tsai, Elizabeth Kuohttp://downloads.hindawi.com/journals/ah/2014/295323.pdf, http://downloads.hindawi.com/journals/ah/2014/295323.xml, http://downloads.hindawi.com/journals/ah/2014/295323.pdf
Translational Research10.1016/j.trsl.2014.10.01020151652306-320Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndromeEdwin K.S. Wong, David Kavanaghhttps://api.elsevier.com/content/article/PII:S1931524414003831?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1931524414003831?httpAccept=text/plain
Clinical Kidney Journal10.1093/ckj/sfaa06220201441126-1135Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumabLilian Monteiro Pereira Palma, Renato George Eick, Gustavo Coelho Dantas, Michele Káren dos Santos Tino, Maria Izabel de Holanda, http://academic.oup.com/ckj/article-pdf/14/4/1126/38462653/sfaa062.pdf, http://academic.oup.com/ckj/article-pdf/14/4/1126/38462653/sfaa062.pdf
Journal of Nephrology10.1007/s40620-021-01125-82021351317-321COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapyJasmeet Gill, Christopher Alan Hebert, Gates Burton Colberthttps://link.springer.com/content/pdf/10.1007/s40620-021-01125-8.pdf, https://link.springer.com/article/10.1007/s40620-021-01125-8/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40620-021-01125-8.pdf
International Medical Case Reports Journal10.2147/imcrj.s906402015235Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumabGregory Greenwoodhttps://www.dovepress.com/getfile.php?fileID=27499
Hematology, Transfusion and Cell Therapy10.1016/j.htct.2020.02.0012021433364-367Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumabMoataz Ellithi, Mahum Shahid, Hafez Mohammad Abdullah, Jonathan Bleekerhttps://api.elsevier.com/content/article/PII:S2531137920300286?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2531137920300286?httpAccept=text/plain